Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 17, 2025Journal of Hematology & OncologyOpen Access

Nanomaterials-driven in situ vaccination: a novel frontier in tumor immunotherapy

View Full Paper
Ask AI
Bookmark
Share

Authors

NLNaimeng LiuXWXiangyu WangZWZhongzhao Wang

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Liu et al. (2025) studied this question.

synapsesocial.com/papers/6a0cbd0ced9ffa0cbfaddc43https://doi.org/10.1186/s13045-025-01692-4
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Safety and Tolerability of Weekly Genexol-PM, a Cremophor-Free Polymeric Micelle Formulation of Paclitaxel, with Carboplatin in Gynecologic Cancer: A Phase I Study2023 · 25 citations
  2. 2Targeting immunogenic cell death in cancer2020 · 934 citations
  3. 3Vaccine Therapies for Cancer: Then and Now2021 · 217 citations
  4. 4Anticancer drug resistance: An update and perspective2021 · 388 citations
  5. 5Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death2005 · 1,513 citations